Director Orit Geva-Dvash sells 4,116 CAMT shares (NASDAQ: CAMT)

Rhea-AI Filing Summary

CAMT reported insider sale activity by director Orit Geva-Dvash. The filing lists two dispositions of Ordinary shares: 11/26/2025 sale of 1,877 shares for $197,085.00 and 12/02/2025 sale of 2,239 shares for $250,768.00.

The transactions are presented on a Form 144 notification of proposed sale under securities rules; the entries identify the broker as Oppenheimer & Co. Inc. and the exchange as NASDAQ.

Insights

Corporate Governance / Insider Transactions Analyst

Routine Form 144 sales by a reporting person; no new corporate actions disclosed.

The excerpt lists two ordinary share dispositions by Orit Geva-Dvash on 11/26/2025 and 12/02/2025, showing 1,877 and 2,239 shares with corresponding amounts $197,085.00 and $250,768.00.

These entries are notification filings for brokered resale transactions (broker: Oppenheimer & Co. Inc.); cash‑flow recipient is not separately stated beyond the recorded sale proceeds. Subsequent filings would show settlement details if material.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Oppenheimer & Co. Inc. 85 Broad St. New York NY 10004	2271	347712.81	45449306	02/24/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	01/24/2022	PSU	Issuer			4516	01/24/2022	NA
Ordinary	01/24/2022	Restricted Stock Units	Issuer			6774	01/24/2022	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Orit Geva-Dvash INDUSTRIAL ZONE PO BOX 544 MIGDAL HAEMEK L3 2310501	Ordinary	11/26/2025	1877	197085.00
Orit Geva-Dvash INDUSTRIAL ZONE, PO BOX 544 MIGDAL HAEMEK L3 2310501	Ordinary	12/02/2025	2239	250768.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What insider sales does CAMT's Form 144 show?

The Form 144 lists two sales by Orit Geva-Dvash totaling 4,116 shares. It records 1,877 shares on 11/26/2025 for $197,085.00 and 2,239 shares on 12/02/2025 for $250,768.00.

Who handled the sales reported in CAMT's filing?

The broker identified is Oppenheimer & Co. Inc.. The filing shows the broker's address as 85 Broad St., New York, NY and lists the trading venue as NASDAQ in the excerpt.

Does the Form 144 state proceeds received by CAMT?

No; the Form 144 records proceeds associated with the reported disposals but does not state that CAMT received any proceeds. The amounts shown are the reported sale values for the disposals.

Are these Form 144 entries unusual or routine for CAMT?

These entries are routine notification filings for proposed resale of insider-held shares. The excerpt lists specific share counts and sale amounts without indicating any corporate action or material change.

Will this Form 144 change CAMT's outstanding share count?

The Form 144 reports sales by a reporting person and does not state any change to CAMT's shares outstanding. Outstanding share figures are not included in the provided excerpt.